Showing results (21-30 of 37) with videos related to
Sort By:
Pageof 4
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 19, 2005
cTnT can be a useful marker for early detection of anthracycline cardiotoxicityS Kilickap, I Barista, E Akgul, et al.American Journal of Hematology|December 10, 1999
The significance of the bone marrow biopsy pattern in chronic lymphocytic leukemia: a prognostic dilemmaN Zengin, A Kars, A Sungur, et al.Journal of Surgical Oncology|April 1, 1997
Multiple lymphomatous polyposisA Kadayifçi, M Benekli, M C Savaş, et al.Japanese Journal of Cancer Research : Gann|December 1, 1994
Non-Hodgkin's lymphomas in Turkey: eighteen years' experience at the Hacettepe UniversityI Barista, G Tekuzman, D Firat, et al.Tumori|July 1, 1995
Non-Hodgkin's lymphomas of the tonsil: a retrospective analysis of twenty-eight patients with primary tonsillary lymphomaI Barişta, G Tekuzman, I Güllü, et al.Cancer Investigation|January 1, 1996
High-dose ifosfamide by infusion with Mesna in advanced refractory sarcomasI Güllü, S Yalçin, G Tekuzman, et al.Journal of Chemotherapy (Florence, Italy)|August 1, 1996
Ifosfamide, mesna and epirubicin as second-line chemotherapy in advanced breast cancerS Kiraz, E Baltali, N Güler, et al.Hematology (Amsterdam, Netherlands)|July 14, 2016
Granulocyte-Colony Stimulating Factor (G-CSF) Administration for Chemotherapy-Induced NeutropeniaŞ Yalçin, N Güler, E Kansu, et al.Tumori|March 1, 1997
Ifosfamide and etoposide in previously treated patients with advanced breast cancerS Kiraz, E Baltali, N Güler, et al.Acta Oncologica (Stockholm, Sweden)|June 20, 2000
Primary breast lymphomas--a retrospective analysis of twelve casesI Barişta, E Baltali, G Tekuzman, et al.Pageof 4